Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Amiodarone  Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/28/2020 5 1
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Ethyl 2-[(E)-[[1-[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazol-5-yl]cyclopropyl]-pyridin-2-ylmethylidene]amino]oxyacetate Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Bis(5-amidino-2-benzimidazolyl)methane ketone Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Metocurine Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0